Encorafenib and binimetinib followed by radiotherapy for patients with symptomatic BRAF mutated melanoma brain metastases: GEM1802/E-BRAIN clinical trial

被引:2
|
作者
Marquez-Rodas, I. [1 ]
Arance Fernandez, A. M. [2 ]
Berciano Guerrero, M. A. [3 ]
Garcia Castano, A. [4 ]
Alamo De La Gala, M. D. C. [5 ]
Gonzalez Cao, M. [6 ]
Sanchez Maurino, P. [7 ]
Diaz Beveridge, R. P. [8 ]
Valduvieco, I. [9 ]
Delgado, R. [10 ]
Prada, P. J. [11 ]
Puertas, E. [12 ]
Romero, J. L. [13 ]
Conde, A. [14 ]
Alvarez, A. [15 ]
Berrocal, A. [16 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Fdn Invest Biomed, Madrid, Spain
[2] Hosp Clin Barcelona, Med Oncol Dept, Barcelona, Spain
[3] Hosp Reg Univ Malaga Carlos Haya, Oncol Dept, Malaga, Spain
[4] HUMV Hosp Univ Marques Valdecilla, Med Oncol Dept, Santander, Spain
[5] Hosp Univ Virgen Macarena, Med Oncol Dept, Seville, Spain
[6] Hosp Univ Dexeus, Med Oncol, Barcelona, Spain
[7] Hosp Univ Reina Sofia, Med Oncol Dept, Cordoba, Spain
[8] Hosp Univ & Politecn La Fe, Med Oncol Dept, Valencia, Spain
[9] Hosp Clin Barcelona, Radiat Oncol Dept, Barcelona, Spain
[10] Hosp Univ Reg Malaga, Radiat Oncol Dept, Malaga, Spain
[11] HUMV Hosp Univ Marques Valdecilla, Radiat Oncol Dept, Santander, Spain
[12] Hosp Univ Dexeus, Radiat Oncol Dept, Barcelona, Spain
[13] Hosp Reina Sofia, Radiat Oncol Dept, Tudela, Spain
[14] Hosp Univ & Politecn La Fe, Radiat Oncol Dept, Valencia, Spain
[15] Hosp Gen Univ Gregorio Maranon, Radiat Oncol Dept, Madrid, Spain
[16] Hosp Gen Univ Valencia, Med Oncol Dept, Valencia, Spain
关键词
D O I
10.1016/j.annonc.2022.07.952
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
826P
引用
收藏
页码:S926 / S926
页数:1
相关论文
共 50 条
  • [1] Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study)
    Marquez-Rodas, Ivan
    Alvarez, Ana
    Arance, Ana
    Valduvieco, Izaskun
    Berciano-Guerrero, Miguel-angel
    Delgado, Raquel
    Soria, Ainara
    Campos, Fernando Lopez
    Sanchez, Pedro
    Romero, Jose Luis
    Martin-Liberal, Juan
    Lucas, Anna
    Diaz-Beveridge, Roberto
    Conde-Moreno, Antonio-Jose
    de la Gala, Maria del Carmen Alamo
    Garcia-Castano, Almudena
    Prada, Pedro Jose
    Cao, Maria Gonzalez
    Puertas, Enrique
    Vidal, Joana
    Foro, Palmira
    de la Rosa, Carlos Aguado
    Corona, Juan Antonio
    Cerezuela-Fuentes, Pablo
    Lopez, Paco
    Luna, Pablo
    Aymar, Neus
    Puertolas, Teresa
    Sanagustin, Pilar
    Berrocal, Alfonso
    NEURO-ONCOLOGY, 2024,
  • [2] Intracranial activity of encorafenib and binimetinib followed by radiotherapy in patients with BRAF mutated melanoma and brain metastasis: Preliminary results of the GEM1802/EBRAIN-MEL phase II clinical trial
    Marquez-Rodas, I.
    Arance, A.
    Berciano Guerrero, M. A.
    Diaz Beveridge, R.
    Alamo, M. D. C.
    Garcia Castano, A.
    Gonzalez Cao, M.
    Vidal, J.
    Puertolas Hernandez, T.
    Soria, A.
    Aguado De la Rosa, C.
    Sanchez Maurino, P.
    Valduvieco, I.
    Delgado Rico, R.
    Conde, A.
    Foro, P.
    Prada, P. J.
    Puertas, E.
    Alvarez Gonzalez, A.
    Berrocal, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S870 - S870
  • [3] RT after Encorafenib and Binimetinib on BRAF mutated melanoma brain metastases. GEM1802-Phase II
    Alvarez, A.
    Valduvieco, I.
    Arance, A.
    Delgado, R.
    Berciano, M. A.
    Lopez Campos, F.
    Soria, A.
    Romero, J. L.
    Sanchez Maurino, P.
    Lucas, A.
    Martin Liberal, J.
    Prada, P. J.
    Garcia Castano, A.
    Alamo, M. C.
    Puertas, E.
    Gonzalez Cao, M.
    Conde, A.
    Diaz Beveridge, R.
    Corona, J. A.
    Aguado, C.
    Foro, P.
    Vidal, J.
    Lopez Soler, F.
    Cerezuela Fuentes, P.
    Marquez Rodas, I.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1264 - S1264
  • [4] Clinical and Radiographic Response of Leptomeningeal and Brain Metastases to Encorafenib and Binimetinib in a Patient With BRAF V600E-Mutated Lung Adenocarcinoma
    McLoughlin, Erin M.
    Fadul, Camilo E.
    Patel, Sohil H.
    Hall, Richard D.
    Gentzler, Ryan D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) : E269 - E271
  • [5] Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series
    Holbrook, Kourtney
    Lutzky, Jose
    Davies, Michael A.
    Davis, Jessica Michaud
    Glitza, Isabella C.
    Amaria, Rodabe N.
    Diab, Adi
    Patel, Sapna P.
    Amin, Asim
    Tawbi, Hussein
    CANCER, 2020, 126 (03) : 523 - 530
  • [6] Efficacy of encorafenib/binimetinib in patients with metastatic melanoma with brain metastases: Results from the nationwide Dutch Melanoma Treatment Registry
    Bloem, Manja
    van Not, Olivier Jules
    Aarts, Maureen J. B.
    Van den Berkmortel, Franchette
    Blank, Christian U.
    Blokx, Willeke
    Boers-Sonderen, Marye J.
    Bonenkamp, Han J.
    de Groot, Jan Willem
    Haanen, John
    Hospers, Geke
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn
    Stevense-den Boer, Marion
    Van der Veldt, Astrid Aplonia Maria
    Vreugdenhil, Gerard
    Wouters, Michel W. J. M.
    Suijkerbuijk, Karijn
    Van den Eertwegh, Alfonsus Johannes Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Clinical and radiological response of BRAF inhibition and MEK inhibition in patients with brain metastases from BRAF-mutated melanoma
    Foppen, Marnix H. Geukes
    Boogerd, Willem
    Blank, Christian U.
    van Thienen, Johannes V.
    Haanen, John B.
    Brandsma, Dieta
    MELANOMA RESEARCH, 2018, 28 (02) : 126 - 133
  • [8] Neurological benefit of BRAF-inhibition and MEK-inhibition in patients with brain metastases from BRAF-mutated melanoma
    Foppen, M. Geukes
    Boogerd, W.
    Blank, C.
    Haanen, J. B. A. G.
    van Thienen, J. V.
    Brandsma, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [9] Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial
    Bartula, Iris
    Tran, Anh D.
    Nowak, Anna K.
    Ahmed, Tasnia
    Morton, Rachael L.
    Burmeister, Bryan H.
    Dolven-Jacobsen, Kari
    Nobes, Jenny
    Thompson, John F.
    Fogarty, Gerald B.
    Lo, Serigne N.
    Hong, Angela M.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 41
  • [10] Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial
    Gerald Fogarty
    Rachael L Morton
    Janette Vardy
    Anna K Nowak
    Catherine Mandel
    Peta M Forder
    Angela Hong
    George Hruby
    Bryan Burmeister
    Brindha Shivalingam
    Haryana Dhillon
    John F Thompson
    BMC Cancer, 11